A Study to Evaluate the Safety and Efficacy of HB0025 Injection in Patients With Advanced Solid Tumor

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Advanced NSCLC · Advanced Endometrial Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Affiliated Hospital of Hebei University / School of Clinical Medicine, Baoding, Hebei, China

    Contact: Study coordinator (PhD.)
    Contact: Principal Investigator (Aimin Zang, PhD.)
  • Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China

    Contact: Study coordinator (PhD.)
    Contact: Principal Investigator (Baogang Liu, PhD.)
  • The First Affiliated Hospital of Henan University of Science & Technology, Luoyang, Henan, China

    Contact: Study coordinator (PhD.)
    Contact: Principal Investigator (Shegan Gao, PhD.)
  • Henan Cancer Hospital, Zhengzhou, Henan, China

    Contact: Study coordinator (PhD.)
    Contact: Principal Investigator (Qiming Wang, PhD.)
  • The First People'S Hospital of Lianyungãng, Lianyungang, Jiangsu, China

    Contact: Study coordinator (PhD.)
    Contact: Principal Investigator (Xiaodong Jiang, PhD.)
  • Liaoning Cancer Hospital&Institute, Shenyang, Liaoning, China

    Contact: Study coordinator (PhD.)
    Contact: Principal Investigator (Jinghui Bai, PhD.)
  • Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China

    Contact: Study coordinator (Meili Sun, PhD.) · zxyyywsy@163.com · +86(0531)-85695509
    Contact: Principal Investigator (Meili Sun, PhD.)
  • Linyi Cancer Hospital, Linyi, Shandong, China

    Contact: Study coordinator (PhD.)
    Contact: Principal Investigator (Jianhua Shi, PhD.)
  • Weifang People'S Hospital, Weifang, Shandong, China

    Contact: Study coordinator (PhD.)
    Contact: Principal Investigator (Guohua Yu, PhD.)
  • Shanghai Pulmonary Hospital, Shanghai, Shanghai Municipality, China

    Contact: Study coordinator (Caicun Zhou, PhD.) · caicunzhoudr@163.com · +8613301825532
  • Shanxi Cancer hospital, Taiyuan, Shanxi, China

    Contact: Study coordinator (PhD.)
    Contact: Principal Investigator (Xia Song, PhD.)
  • The First Affiliated Hospitalof Xi'an Jiaotong University, Xi’an, Shanxi, China

    Contact: Study coordinator (PhD.)
    Contact: Principal Investigator (Yu Yao, PhD.)
  • The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China

    Contact: Study coordinator (PhD.)
    Contact: Principal Investigator (Chao Dong, PhD.)
  • The First Affiliated Hospitalzhejiang University School of Medicine, Hangzhou, Zhejiang, China

    Contact: Study coordinator (PhD.)
    Contact: Principal Investigator (Jianya Zhou, PhD.)
Study leads
  • Caicun Zhou, PhD.

    Principal Investigator

    Shanghai Pulmonary Hospital, Shanghai, China

  • Jundong Li, PhD.

    Principal Investigator

    Sun Yat-sen University